Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

Am J Kidney Dis. 2021 Sep;78(3):469-470. doi: 10.1053/j.ajkd.2021.05.006. Epub 2021 May 21.

Authors

Hirotaka Komaba¹, Takehiko Wada², Masafumi Fukagawa²

Affiliations

¹ Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan; The Institute of Medical Sciences, Tokai University, Isehara, Japan.
² Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Nephrosis, Lipoid*
Recurrence
SARS-CoV-2

Substances

COVID-19 Vaccines